2020 : European Licensing-out Advisory for Catabasis Pharmaceuticals par gdm5 | Fév 8, 2022 | Feature
2018 : Endo-Pharmaceuticals acquires Bioprojet’s Wakix commercial rights in Canada par gdm5 | Fév 8, 2022 | Feature
